Home / Superinvestors / Baupost Group
Baupost Group
Value
$5.921B
Positions
30
Top 10 weight
79.6%
Holdings
30 stocks| Stock | Shares | Value ▼ | Reported Price | Current Price | vs Reported | 52W | Weight |
|---|---|---|---|---|---|---|---|
| CHENIERE ENERGY INC | 15,365,230 | $1.064B | $69.26 | $308.75 | +345.8% | $188.83 – $330.32 | 18.0% |
| VIASAT INC | 11,533,137 | $695M | $60.26 | $67.72 | +12.4% | $30.35 – $89.81 | 11.7% |
| PIONEER NAT RES CO | 4,065,000 | $563.8M | $138.69 | - | - | - | 9.5% |
| EBAY INC | 9,315,000 | $561.1M | $60.24 | $120.92 | +100.7% | $79.41 – $125.15 | 9.5% |
| MICRON TECHNOLOGY INC | 19,706,035 | $371.3M | $18.84 | $778.31 | +4031.2% | $201.37 – $1,213.56 | 6.3% |
| THERAVANCE INC | 19,815,983 | $358.1M | $18.07 | - | - | - | 6.0% |
| PBF ENERGY INC | 11,025,000 | $313.3M | $28.42 | $71.28 | +150.8% | $26.02 – $91.17 | 5.3% |
| ANTERO RESOURCES CORP | 8,022,863 | $275.5M | $34.34 | $38.74 | +12.8% | $31.38 – $45.15 | 4.7% |
| KERYX BIOPHARMACEUTICALS INC | 25,791,678 | $257.4M | $9.98 | - | - | - | 4.3% |
| ATARA BIOTHERAPEUTICS INC | 4,809,632 | $253.8M | $52.76 | - | - | - | 4.3% |
| FORWARD PHARMA A/S | 5,367,300 | $204.2M | $38.05 | - | - | - | 3.4% |
| SUNEDISON SEMICONDUCTOR LTD | 8,297,979 | $143.3M | $17.27 | - | - | - | 2.4% |
| VERITIV CORP | 2,482,157 | $90.5M | $36.46 | - | - | - | 1.5% |
| THERAVANCE BIOPHARMA INC | 6,420,028 | $83.59M | $13.02 | - | - | - | 1.4% |
| OCWEN FINL CORP | 7,655,703 | $78.09M | $10.20 | - | - | - | 1.3% |
| CITIGROUP INC | 102,553,207 | $75.89M | $0.74 | - | - | - | 1.3% |
| NOVAGOLD RES INC | 21,688,300 | $74.17M | $3.42 | $5.63 | +64.6% | $5.18 – $14.20 | 1.3% |
| CHIPMOS TECH BERMUDA LTD | 3,283,235 | $71.71M | $21.84 | - | - | - | 1.2% |
| FRONTIER COMMUNICATIONS CORP | 13,500,000 | $66.83M | $4.95 | - | - | - | 1.1% |
| KLX INC | 1,500,000 | $66.2M | $44.13 | - | - | - | 1.1% |
| BELLATRIX EXPLORATION COM | 21,840,500 | $50.89M | $2.33 | - | - | - | 0.9% |
| KOSMOS ENERGY LTD | 6,000,000 | $50.58M | $8.43 | $2.23 | -73.5% | $0.87 – $3.27 | 0.9% |
| PARATEK PHARMACEUTICALS INC | 1,544,498 | $39.8M | $25.77 | - | - | - | 0.7% |
| AMERICAN INTL GROUP INC | 1,258,496 | $34.87M | $27.71 | - | - | - | 0.6% |
| Kindred Biosciences, Inc. | 3,013,848 | $20.55M | $6.82 | - | - | - | 0.3% |
| BIOTIE THERAPIES OYJ | 869,643 | $17.37M | $19.97 | - | - | - | 0.3% |
| ALLIANCE ONE INTL INC | 638,364 | $15.26M | $23.91 | - | - | - | 0.3% |
| ALON USA PARTNERS LP | 629,188 | $13.23M | $21.02 | - | - | - | 0.2% |
| SANCHEZ ENERGY CORP | 619,505 | $6.071M | $9.80 | - | - | - | 0.1% |
| NOVACOPPER INC | 10,600,758 | $4.474M | $0.42 | - | - | - | 0.1% |
Combines 32 filed positions into 30 CUSIPs. Positions split across delegated managers are summed.
13F reports long positions only (including long options; shorts and cash excluded) as of quarter end.
Other reported positions
2 items| Stock | Type | Amount / Par | Value |
|---|---|---|---|
| THERAVANCE INC | Principal (bond/note) | 48,230,000 | $45.52M |
| FRONTIER COMMUNICATIONS CORP | Preferred / depositary | 325,000 | $32.47M |
Bonds, notes, preferred/depositary shares, zero-value positions and options (call/put) are listed for completeness but are not counted in the value or position totals — shares only, value above zero, options excluded, preferred excluded (the Dataroma convention). Options are shown as the underlying share count and its value, not as contracts.